A five-minute aliquoting step at the start prevents most of the degradation and concentration drift that otherwise appears during a project.
Key Takeaways
- Repeated freeze-thaw cycles concentrate solute at the ice interface and shift pH during freezing, both of which drive aggregation and chemical degradation.
- Use low-binding tubes, particularly at low concentration where surface adsorption removes a proportionally large fraction of material.
- Store at the temperature supported by stability data, protect from light where aromatic or sulfur residues are present, and minimise headspace.
Why aliquot at all
Repeated freeze-thaw cycles concentrate solute at the ice interface and shift pH during freezing, both of which drive aggregation and chemical degradation. Single-use aliquots eliminate the exposure entirely.
Choosing aliquot size
Match aliquot volume to the amount used in one experiment, so that no vial is thawed more than once. Oversized aliquots recreate the problem, while very small ones increase surface-adsorption losses.
For related mechanism work, see peptide waste disposal.
Consumable choice
Use low-binding tubes, particularly at low concentration where surface adsorption removes a proportionally large fraction of material. Polypropylene is generally preferable to glass for peptide solutions.
Labelling and records
Label with peptide identity, concentration, solvent, date, and the number of freeze-thaw cycles if a vial is reused. Include the batch number so results can be traced back to a certificate of analysis.
Storage conditions
Store at the temperature supported by stability data, protect from light where aromatic or sulfur residues are present, and minimise headspace. Document any excursion rather than assuming it was inconsequential.
Experimental Conditions and Practical Setup
Aliquots are prepared immediately after reconstitution at the volume used for a single experiment, transferred to low-binding tubes, and frozen in a single step. Label preparation happens before the aliquots are made, because the most common failure in this workflow is unlabelled material that cannot be traced back to a batch.
Aliquot sizing trade-off
| Aliquot size | Advantage | Risk |
|---|---|---|
| Matched to one experiment | No repeat thaw | More tubes to manage |
| Larger than needed | Fewer tubes | Recreates freeze-thaw damage |
| Very small volumes | Minimal waste | Higher proportional adsorption loss |
| Single-use with carrier protein | Reduces adsorption | Carrier may interfere downstream |
Practical Notes for the Bench
- Size aliquots to a single experiment so no vial is thawed twice.
- Use low-binding polypropylene, especially at low concentration.
- Record batch number on every aliquot for traceability.
Frequently Asked Questions
Why not just freeze and thaw as needed?
Freeze-thaw cycling concentrates the peptide at the ice interface and shifts pH, driving aggregation and degradation.
What tube material should I use?
Low-binding polypropylene, because glass and standard plastics adsorb peptide, which matters most at low concentration.
How should aliquots be labelled?
With identity, concentration, solvent, date, batch number, and any freeze-thaw count if reused.
Can I refreeze a thawed aliquot?
It should not be routine practice. Each additional cycle concentrates the peptide at the ice interface and shifts pH during freezing, so thawed material is used or discarded and the event recorded.
Related Reading
- peptide waste disposal
- peptide handling checklist
- peptide inventory management
- amylin pramlintide
- antihypertensive peptides
References & Further Reading
- Nkuna DX et al. The stability of C-peptide and insulin in plasma and serum samples under different storage conditions. Clin Chem Lab Med. 2023. PubMed 37409980
- Zheng G et al. Stability of serum cytokeratin 18-M30 under different storage conditions for drug-induced liver injury assessment. Pak J Pharm Sci. 2026. PubMed 42262209
- Planyavsky M et al. A longitudinal proteomic assessment of peptide degradation and loss under acidic storage conditions. Anal Biochem. 2015. PubMed 25479603
- Peptide literature search on PubMed
- Full-text archive at PubMed Central
- FDA guidance documents on peptide drug products
The notes below reflect common laboratory practice and open literature. They are not clinical recommendations, and peptides discussed are research materials unless stated otherwise.
Reviewed by James Okoro, BSc, Laboratory Operations & Documentation.